Developer docs
API playgroundTry for free, no card

Search company profiles

Bioassay

Full company profile

uuid00234cu

Namestring
Bioassay
Legal namestring
Bioassay GmbH
Company typeenum
Private
Founded yearint
2002
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHeidelberg, Germany
HQ citystring
Heidelberg
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
bioanalytical contract research, potency assay development, GMP potency testing, biologics testing services, GLP toxicology services
Industry3 codes
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Contract Research Organization (CRO) Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

B2B contract research services providing bioanalytical testing, assay development, validation, and routine testing for pharmaceutical and biotech companies. Revenue generated through project-based contracts for development, validation, and release testing services.

bioassay-online.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Bioassay GmbH is a bioanalytical contract research organization (CRO) that develops, validates, and performs routine testing of bioassays for biologics and drug products. Core offerings include potency assay development and execution, efficacy and safety assessment studies, physico-chemical HPLC analysis, GLP toxicology services, and GMP potency testing for veterinary biologics — all delivered under GMP and GLP certifications from a 2,000 m² facility in Heidelberg, Germany.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bioassay is a bioanalytical contract research organization offering a unified suite of services for biologics and drug product development. The core portfolio includes BioPharma Potency (potency assay development and execution for biologics and proteins), BioPharma Efficacy & Safety (efficacy models and safety assessment studies), Physico-Chemical Analysis (HPLC-based qualitative and quantitative analysis), GLP Services (acute toxicity and skin sensitization studies), and Veterinary Products (GMP potency testing for veterinary biologics). Supporting these service lines are assay development, validation, release testing, and stability studies capabilities. All services are performed under GMP and GLP certifications at their 2000 m2 facility in Heidelberg Technology Park.

Product and service5 records
1BioPharma Potency
CategoryBioanalytical Contract Research
Description

Develops and executes potency assays for biologics, proteins, and active pharmaceutical ingredients under established GMP quality guidelines. Used by pharmaceutical and biotech companies to evaluate potency of biologics from discovery through commercial release.

2BioPharma Efficacy & Safety
CategoryBioanalytical Contract Research
Description

Establishes efficacy models to test biosimilars or active pharmaceutical ingredients and offers safety assessment studies to support product registration. Used by pharma and biotech developers preparing regulatory submissions.

3Physico – Chemical Analysis
CategoryAnalytical Testing Services
Description

Uses state-of-the-art, highly sensitive HPLC equipment for qualitative and quantitative analysis under both GMP and non-GMP conditions. Used by pharmaceutical companies requiring physico-chemical characterization of compounds.

4GLP Services
CategoryGLP Toxicology Services
Description

Supports compound selection before registration with complementary in vitro/in vivo acute toxicity and skin sensitization services under GLP guidelines. Used by pharma and biotech companies preparing preclinical registration packages.

5Veterinary Products
CategoryVeterinary Biologics Testing
Description

GMP potency testing services for veterinary biologics, ensuring animal veterinary products are safe and effective for use in animals. Used by veterinary biologics manufacturers for regulatory-compliant batch release testing.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Bioassay GmbH is a subsidiary company of Reaction Biology. Reaction Biology operates as the parent company providing strategic direction and operational support for the bioanalytical services subsidiary.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Bioassay's parent company, Reaction Biology operates early-discovery CRO services with overlapping scientific talent and client base in bioanalytical and biologics testing. Closest organizational and commercial comparable.

2NorthEast BioAnalytical Laboratories
TypeEmerging player
Description

NE BioLab provides regulated bioanalytical and potency assay services for biologics and biosimilars. Niche CRO comparable to Bioassay in scale and service mix.

TypeBroad incumbent
Description

Charles River's Biologics Testing Solutions offer GMP lot-release, stability, and cell-based assay services. A broad incumbent competing for the same biologics sponsors with substantially greater geographic reach.

TypeBroad incumbent
Description

Intertek offers GMP bioanalytical, potency, and physico-chemical testing for biologics with global reach. Comparable to Bioassay in service scope and quality system positioning.

TypeEmerging player
Description

While primarily a bioprocessing supplier, Sartorius operates in the cell-based assay and biologics characterization space, providing tools and increasingly services that overlap with Bioassay's potency assay work for cell and gene therapies.

TypeDirect peer
Description

Bionova Scientific is a GMP biologics-focused testing CRO offering cell-based potency, release, and stability services. A specialty peer with very similar scope and target customer profile.

TypeDirect peer
Description

BioAgilytix specializes in bioanalytical services for biologics, including cell-based potency assays and immunogenicity. Closely comparable specialty CRO targeting the same biologics sponsors with similar assay modalities.

TypeBroad incumbent
Description

Eurofins' BioPharma Product Testing network provides GMP potency, stability, and physico-chemical testing for biologics at global scale. Most direct large-scale competitor for Bioassay's core potency and release testing services.

TypeBroad incumbent
Description

WuXi AppTec offers large-scale GMP bioanalytical and biologics testing services globally. Competes for biologics potency and release testing work with significantly broader capacity than Bioassay.

TypeBroad incumbent
Description

SGS provides GMP-compliant biologics testing, potency assays, and stability studies across a global lab network. Overlaps with Bioassay on regulated potency and release testing for biologics and vaccines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bioassay

Contract Research Organization (CRO) Servicesbioassay-online.de

Bioassay firmographics

Firmographics
Name
Bioassay
Legal name
Bioassay GmbH
Website
https://bioassay-online.de
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Bioassay industry classification

Industry
Product category
Contract Research Organization (CRO) Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)

Keywords

  • Bioanalytical contract research
  • Potency assay development
  • GMP potency testing
  • Biologics testing services
  • GLP toxicology services

Where Bioassay is headquartered

Location

Headquarters

HQ city
Heidelberg
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Bioassay business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Research Services: B2B contract research services providing bioanalytical testing, assay development, validation, and routine testing for pharmaceutical and biotech companies. Revenue generated through project-based contracts for development, validation, and release testing services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Bioassay product offering

Product offering

Core offering

Bioassay GmbH is a bioanalytical contract research organization (CRO) that develops, validates, and performs routine testing of bioassays for biologics and drug products. Core offerings include potency assay development and execution, efficacy and safety assessment studies, physico-chemical HPLC analysis, GLP toxicology services, and GMP potency testing for veterinary biologics — all delivered under GMP and GLP certifications from a 2,000 m² facility in Heidelberg, Germany.

Product overview

Bioassay is a bioanalytical contract research organization offering a unified suite of services for biologics and drug product development. The core portfolio includes BioPharma Potency (potency assay development and execution for biologics and proteins), BioPharma Efficacy & Safety (efficacy models and safety assessment studies), Physico-Chemical Analysis (HPLC-based qualitative and quantitative analysis), GLP Services (acute toxicity and skin sensitization studies), and Veterinary Products (GMP potency testing for veterinary biologics). Supporting these service lines are assay development, validation, release testing, and stability studies capabilities. All services are performed under GMP and GLP certifications at their 2000 m2 facility in Heidelberg Technology Park.

Differentiator

Problem solved

Functional benefit

Products and services

  • BioPharma Potency Develops and executes potency assays for biologics, proteins, and active pharmaceutical ingredients under established GMP quality guidelines. Used by pharmaceutical and biotech companies to evaluate potency of biologics from discovery through commercial release.
  • BioPharma Efficacy & Safety Establishes efficacy models to test biosimilars or active pharmaceutical ingredients and offers safety assessment studies to support product registration. Used by pharma and biotech developers preparing regulatory submissions.
  • Physico – Chemical Analysis Uses state-of-the-art, highly sensitive HPLC equipment for qualitative and quantitative analysis under both GMP and non-GMP conditions. Used by pharmaceutical companies requiring physico-chemical characterization of compounds.
  • GLP Services Supports compound selection before registration with complementary in vitro/in vivo acute toxicity and skin sensitization services under GLP guidelines. Used by pharma and biotech companies preparing preclinical registration packages.
  • Veterinary Products GMP potency testing services for veterinary biologics, ensuring animal veterinary products are safe and effective for use in animals. Used by veterinary biologics manufacturers for regulatory-compliant batch release testing.

Companies that use Bioassay

Customer profile

Segments2 records

Ideal customer profiles2 records

Bioassay technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Bioassay partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Reaction BiologycoreStrategic or Co-development PartnerBioassay GmbH is a subsidiary company of Reaction Biology. Reaction Biology operates as the parent company providing strategic direction and operational support for the bioanalytical services subsidiary.

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Bioassay competitors and assessment

Company assessment

Direct peers

  • Reaction Biology: Bioassay's parent company, Reaction Biology operates early-discovery CRO services with overlapping scientific talent and client base in bioanalytical and biologics testing. Closest organizational and commercial comparable.
  • Bionova Scientific: Bionova Scientific is a GMP biologics-focused testing CRO offering cell-based potency, release, and stability services. A specialty peer with very similar scope and target customer profile.
  • BioAgilytix: BioAgilytix specializes in bioanalytical services for biologics, including cell-based potency assays and immunogenicity. Closely comparable specialty CRO targeting the same biologics sponsors with similar assay modalities.

Emerging players

  • NorthEast BioAnalytical Laboratories: NE BioLab provides regulated bioanalytical and potency assay services for biologics and biosimilars. Niche CRO comparable to Bioassay in scale and service mix.
  • Sartorius (Bioprocess & Lab Products): While primarily a bioprocessing supplier, Sartorius operates in the cell-based assay and biologics characterization space, providing tools and increasingly services that overlap with Bioassay's potency assay work for cell and gene therapies.

Broad incumbents

  • Charles River Laboratories: Charles River's Biologics Testing Solutions offer GMP lot-release, stability, and cell-based assay services. A broad incumbent competing for the same biologics sponsors with substantially greater geographic reach.
  • Intertek Pharmaceutical Services: Intertek offers GMP bioanalytical, potency, and physico-chemical testing for biologics with global reach. Comparable to Bioassay in service scope and quality system positioning.
  • Eurofins BioPharma Product Testing: Eurofins' BioPharma Product Testing network provides GMP potency, stability, and physico-chemical testing for biologics at global scale. Most direct large-scale competitor for Bioassay's core potency and release testing services.
  • WuXi AppTec (Bioanalytical Services): WuXi AppTec offers large-scale GMP bioanalytical and biologics testing services globally. Competes for biologics potency and release testing work with significantly broader capacity than Bioassay.
  • SGS Life Sciences: SGS provides GMP-compliant biologics testing, potency assays, and stability studies across a global lab network. Overlaps with Bioassay on regulated potency and release testing for biologics and vaccines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Bioassay social profiles

Digital presence

Bioassay compliance and trust

Trust signal

Compliance3 records

Bioassay financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bioassay leadership team

Management profile

Number of profiles

Bioassay funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bioassay M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioassay

What does Bioassay do?

Bioassay GmbH is a bioanalytical contract research organization (CRO) that develops, validates, and performs routine testing of bioassays for biologics and drug products. Core offerings include potency assay development and execution, efficacy and safety assessment studies, physico-chemical HPLC analysis, GLP toxicology services, and GMP potency testing for veterinary biologics — all delivered under GMP and GLP certifications from a 2,000 m² facility in Heidelberg, Germany.

Is Bioassay a public or private company?

Bioassay is a private company. It is classified as corporate owned and is currently operating.

When was Bioassay founded?

Bioassay was founded in 2002. It employs 11 to 50 people.

Where is Bioassay based?

Bioassay is headquartered in Heidelberg, Germany, in the Europe region.

How does Bioassay make money?

One revenue line is on record: contract Research Services.

Who are Bioassay's main competitors?

Direct peers on record are Reaction Biology, Bionova Scientific and BioAgilytix. Emerging players are NorthEast BioAnalytical Laboratories and Sartorius (Bioprocess & Lab Products). Broad incumbents are Charles River Laboratories, Intertek Pharmaceutical Services, Eurofins BioPharma Product Testing, WuXi AppTec (Bioanalytical Services) and SGS Life Sciences.

Does Bioassay have an API?

No public API is recorded for Bioassay.

What industry is Bioassay in?

Bioassay's product category is Contract Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGADAH, Cell-Based & Potency Assays (Bioassays), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireReaction Biology Acquires Bioassay GmbH Increasing Large Molecule Capabilities Within Its Robust Portfolio of Drug Discovery and Development ServicesReaction Biology Corporation has closed a definitive agreement to acquire Bioassay Labor für biologische Analytik GmbH and its subsidiary Peptide Specialty Laboratories GmbH. The transaction adds large molecule capabilities, GMP and GLP accredited facilities, and talent in Germany to Reaction's drug discovery and development services portfolio.ContractpharmaReaction Biology Acquires Bioassay GmbH and PSLReaction Biology Corporation has closed on a definitive agreement to acquire Bioassay Labor für biologische Analytik GmbH and its subsidiary, Peptide Specialty Laboratories (PSL), based in Heidelberg, Germany. This transaction allows Reaction Biology to expand its presence in Germany and enhance its global portfolio of GMP-accredited potency assays, GLP-compliant services, and peptide synthesis capabilities. The acquisition is driven by increasing market demand for large molecule drug discovery services among biopharmaceutical companies.ReactionbiologyReaction Biology Acquires Bioassay GmbH Increasing Large Molecule Capabilities Within Its Robust Portfolio of Drug Discovery and Development ServicesReaction Biology Corporation has acquired Bioassay Labor für biologische Analytik GmbH and its subsidiary Peptide Specialty Laboratories GmbH, enhancing its capabilities in drug discovery and development services. This acquisition adds expertise in large molecule services and complies with GMP and GLP standards, addressing increasing market demand for biopharmaceutical services. The move positions Reaction to better serve clients in the oncology and serious disease treatment sectors.